FINWIRES · TerminalLIVE
FINWIRES

$SLN

55 stories mentioning SLNUpdated 2d ago

Every FINWIRES story that references SLN, newest first.

What are analysts saying about SLN?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on SLN?

Asia Markets

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.53% to 1,939.78 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia (NOK) and lender Banco Bilbao Vizcaya Argentaria (BBVA), which were up 3.1% and 1.8% respectively. They were followed by medical device maker EDAP TMS (FOCL) and lender Banco Santander (SAN), which increased 1.7% and 1.4% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and pharmaceutical company Novo Nordisk (NVO), which dropped 3.5% and 2.8% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and oil and gas company Eni (E), which lost 1.5% and 1.3% respectively.The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Mereo BioPharma Group (MREO), which surged 86% and 13% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and software firm Endava (DAVA), which advanced 2.7% and 1.8% respectively.The decliners from the UK and Ireland were led by biotech firms Trinity Biotech (TRIB) and Autolus Therapeutics (AUTL), which fell 12% and 4.1% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and communications company WPP (WPP), which were down 1.1% and 1% respectively.

$AKTX$AUTL$BBVA$BDRX$CLLS$DAVA$DBVT$E$FOCL$MREO$NOK$NVO$SAN$SLN$TRIB$WPP
Asia Markets

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, declining 0.46% to 1,952.20 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor (EQNR) and biotech firm Evaxion (EVAX), which advanced 4% and 3.5% respectively. They were followed by telecommunications company Nokia (NOK) and oil and gas company Eni (E), which increased 2.1% and 1.4% respectively.The decliners from continental Europe were led by brewing company Anheuser-Busch InBev (BUD) and biopharmaceutical company Cellectis (CLLS), which dropped 2.1% and 1.9% respectively. They were followed by lender Banco Santander (SAN) and internet browser company Opera (OPRA), which lost 1.7% and 1.6% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics (AKTX) and biotech firm Trinity Biotech (TRIB), which rose 3.7% and 3.6% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and oil and gas company BP (BP), which were up 1.4% and 1.2% respectively.The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Mereo BioPharma Group (MREO), which fell 1.9% and 1.8% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics (BCYC) and lender Barclays (BCS), which were down 1.7% and 1.1% respectively.

$AKTX$AUTL$BCS$BCYC$BP$BUD$CLLS$E$EQNR$EVAX$MREO$NOK$OPRA$SAN$SLN$TRIB
Asia Markets

European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading

European equities traded in the US as American depositary receipts were tracking lower late Tuesday morning, declining 0.46% to 1,968.02 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and telecommunications company Nokia (NOK), which rose 2.6% and 6.5% respectively. They were followed by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which were up 2.3% and 2.2% respectively.The decliners from continental Europe were led by biotech firm BioNTech (BNTX) and internet browser company Opera (OPRA), which fell 4.9% and 2% respectively. They were followed by biopharmaceutical companies argenx (ARGX) and Cellectis (CLLS), which were down 2.2% and 0.3%, respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics (AKTX) and oil and gas company BP (BP), which increased 2% and 2.5% respectively. They were followed by mining company BHP Group (BHP) and oil and gas company Shell (SHEL), which advanced 3.4% and 2.5% respectively.The decliners from the UK and Ireland were led by software firm Endava (DAVA), which lost 6.2%. It was followed by biotech firm Autolus Therapeutics (AUTL) and pharmaceutical company Silence Therapeutics (SLN), which dropped 3.6% and 3.4% respectively.

$AKTX$ARGX$AUTL$BHP$BNTX$BP$CLLS$DAVA$E$EQNR$EVAX$NOK$OPRA$SHEL$SLN
Asia Markets

European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading

European equities traded in the US as American depositary receipts opened the week slightly lower late Monday morning, declining 0.12% to 1,952.52 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical company Ascendis Pharma (ASND) and 3D printer company Materialise (MTLS), which rose 6.6% and 2.8%, respectively. They were followed by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which were up 2.7% and 2.6%, respectively.The decliners from continental Europe were led by internet browser company Opera (OPRA) and biotech firm Evaxion (EVAX), which fell 1.9% and 1.7% respectively. They were followed by telecommunications company Nokia (NOK) and accommodations booking site trivago (TRVG), which were down 1.3% and 1.2% respectively.The gainers from the UK were led by biopharmaceutical company Mereo BioPharma Group (MREO) and software firm Endava (DAVA), which advanced 14% and 1.9% respectively. They were followed by oil and gas companies BP (BP) and Shell (SHEL), which increased 1.3% and 0.9% respectively.The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and Biodexa Pharmaceuticals (BDRX), which dropped 16% and 5.9% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and pharmaceutical company Silence Therapeutics (SLN), which increased 3.7% and 2.3% respectively.

$AKTX$ASND$BDRX$BP$DAVA$E$EQNR$EVAX$MREO$MTLS$NCNA$NOK$OPRA$SHEL$SLN$TRVG
Asia Markets

European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading

European equities traded in the US as American depositary receipts were marginally higher late Tuesday morning, rising 0.1% to 1,982.02 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotechnology companies Cellectis (CLLS) and DBV Technologies (DBVT), which advanced 6% and 5% respectively. They were followed by medical device maker EDAP TMS (FOCL) and accommodations booking site trivago (TRVG), which increased 3.8% and 1% respectively.The decliners from continental Europe were led by lender Banco Bilbao Vizcaya Argentaria (BBVA) and oil and gas company Eni (E), which fell 1.8% and 1.7% respectively. They were followed by oil and gas company Equinor (EQNR) and consumer goods company Unilever (UL), which were down 1.5% and 0.7% respectively.The gainers from the UK were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which climbed 14.2% and 7.2% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and software firm Endava (DAVA), which were up 4.9% and 1.3% respectively.The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and alcoholic beverage company Diageo (DEO), which dropped 5.7% and 1.6% respectively. They were followed by communications group WPP (WPP) and medical device maker Smith & Nephew (SNN), which lost 1.4% and 1.2% respectively.

$AKTX$BBVA$BDRX$CLLS$DAVA$DBVT$DEO$E$EQNR$FOCL$SLN$SNN$TRIB$TRVG$UL$WPP
Asia Markets

European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading

European equities traded in the US as American depositary receipts were trending lower in late Tuesday morning trading, declining 0.50% to 1,960.50 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by software firm SAP (SAP) and pharmaceutical company Sanofi (SNY), which increased 1.7% and 1.6% respectively. They were followed by healthcare tech company Royal Philips (PHG) and biopharmaceutical company DBV Technologies (DBVT), which were up 1.5% and 1.3% respectively.The decliners from continental Europe were led by telecommunications company Nokia (NOK) and biopharmaceutical company Cellectis (CLLS), which lost 3.8% and 2.9% respectively. They were followed by biotech firm Evaxion (EVAX) and furniture maker Natuzzi (NTZ), which dropped 1.6% and 1.5% respectively.The gainers from the UK were led by software firm Endava (DAVA) and communications company WPP (WPP), which advanced 4.1% and 2.6% respectively. They were followed by pharmaceutical company AstraZeneca (AZN) and biotech company Trinity Biotech (TRIB), which rose 1.8% and 1.4% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company Silence Therapeutics (SLN), which fell 2.5% and 2.4% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and lender Barclays (BCS), which were down 2.2% and 1.7% respectively.

$AKTX$AZN$BCS$CLLS$DAVA$DBVT$EVAX$MREO$NOK$NTZ$PHG$SAP$SLN$SNY$TRIB$WPP
Asia Markets

European Equities Traded in the US Rise in Thursday Trading

European equities traded in the US as American depositary receipts were higher late Thursday morning, rising 0.45% to 1,969.72 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and biotech firm Evaxion (EVAX), which rose 4.9% and 2.9% respectively. They were followed by telecommunications company Nokia (NOK) and healthcare tech company Royal Philips (PHG), which increased 2.8% and 1.9% respectively.The decliners from continental Europe were led by Ascendis Pharma (ASND) and petroleum refiner Equinor (EQNR), which fell 3.8% and 2.8% respectively. They were followed by oil and gas company Eni (E) and pharmaceutical company Novo Nordisk (NVO), which were down 1.8% and 0.7% respectively.The gainers from the UK were led by Autolus Therapeutics (AUTL) and Silence Therapeutics (SLN), which rose 4.7% and 3.6% respectively. They were followed by software firm Endava (DAVA) and British American Tobacco (BTI), which were up 3.3% and 2.9% respectively.The decliners from the UK and Ireland were led by Trinity Biotech (TRIB) and Mereo BioPharma Group (MREO), which lost 3% and 2.5% respectively. They were followed by mining firm BHP (BHP) and oil and gas company BP (BP), which fell 1.8% and 1.5% respectively.

$ASND$AUTL$BHP$BP$BTI$CLLS$DAVA$E$EQNR$EVAX$MREO$NOK$NVO$PHG$SLN$TRIB
Asia Markets

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

European equities traded in the US as American depositary receipts were tracking higher late Tuesday morning, rising 0.46% to 1,966.35 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and semiconductor company Sequans Communications (SQNS), which advanced 4.7% and 2.6% respectively. They were followed by telecommunications company Nokia (NOK) and medical device maker EDAP TMS (FOCL), which increased 3.2% and 1.3% respectively.The decliners from continental Europe were led by brewing company Anheuser-Busch InBev (BUD) and biopharmaceutical company DBV Technologies (DBVT), which dropped 3.1% and 1% respectively. They were followed by consumer goods company Unilever (UL) and pharmaceutical company Novo Nordisk (NVO), which were off 0.9% and 1% respectively.The gainers from the UK were led by biopharmaceutical company Mereo BioPharma Group (MREO) and biotech firm Autolus Therapeutics (AUTL), which surged 27% and 8% respectively. They were followed by biotech company Trinity Biotech (TRIB) and biopharmaceutical company Akari Therapeutics (AKTX), which rose 3.5% and 1% respectively.The decliners from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and alcoholic beverage company Diageo (DEO), which fell 2% and 1.7% respectively. They were followed by insurance firm Prudential (PUK), which was down 2.1%.

$AKTX$AUTL$BUD$CLLS$DBVT$DEO$FOCL$MREO$NOK$NVO$PUK$SLN$SQNS$TRIB$UL
Wire

Silence Therapeutics' Divesiran Data Support Best-in-Class Potential, Morgan Stanley Says

Silence Therapeutics' (SLN) Phase 2 results for divesiran in polycythemia vera showed stronger activity than a competing treatment and a "more convenient dosing profile," supporting the drug's potential as a best-in-class therapy, Morgan Stanley said in a report Monday.Divesiran produced a 69% placebo-adjusted response rate across pooled treatment arms, compared with 44% for Protagonist Therapeutics' (PTGX) rusfertide, while offering dosing every six or 12 weeks versus once weekly for the competing therapy, the report said.The investment bank also highlighted a favorable safety profile, with 91% of patients in the divesiran arms avoiding phlebotomy during the study and 44 of 48 people who completed the study choosing to enter the open label extension, according to the report.Silence plans to present detailed Phase 2 data at the American Society of Hematology meeting in December, meet with the US Food and Drug Administration by the end of 2026 and begin a Phase 3 study in the first half of 2027, the report said.Morgan Stanley reiterated its overweight rating on Silence Therapeutics and raised its price target to $32 from $25.Price: $15.14, Change: $-0.29, Percent Change: -1.88%

$PTGX$SLN
Sectors

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.4%.The iShares Biotechnology ETF (IBB) climbed 1%.In corporate news, Eli Lilly (LLY) received UK authorization for orforglipron, marketed as Foundayo, a once-daily tablet for weight management and type 2 diabetes, the Medicines and Healthcare products Regulatory Agency said Monday. Lilly shares gained 3.7%.Teledyne Technologies (TDY) has agreed to acquire X-ray imaging components manufacturer Varex Imaging (VREX) in a $1.1 billion deal that will expand its X-ray device portfolio to include oncology detectors. Teledyne shares were up 0.3%, and Varex surged 48%.Thermo Fisher Scientific (TMO) expects to increase its customer base in India by 15% to 20% over the next five years, driven by growth in biopharma research and manufacturing, Reuters reported, citing Srinath Venkatesh, the company's managing director for India and South Asia. Thermo Fisher shares were up 0.7%.Silence Therapeutics (SLN) shares jumped 27% after it said Monday its phase 2 trial of divesiran to treat Polychthemia Vera, a form of blood cancer, met its primary endpoint.

$LLY$SLN$TDY$TMO$VREX
Sectors

Sector Update: Healthcare

Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.4%.The iShares Biotechnology ETF (IBB) climbed 1%.In corporate news, Silence Therapeutics (SLN) shares jumped 25% after it said Monday its phase 2 trial of divesiran to treat Polychthemia Vera, a form of blood cancer, met its primary endpoint.

$SLN
Wire

Silence Therapeutics' Divesiran to Treat Polychthemia Vera Meets Primary, Secondary Endpoints

Silence Therapeutics (SLN) said Monday its phase 2 trial of divesiran to treat Polychthemia Vera, a form of blood cancer, met its primary endpoint of the proportion of patients achieving a dose response, defined as the absence of phlebotomy and hematocrit below 45% during weeks 18 and 36.Around 88% of the patients achieved a dose response compared with 19% for placebo. The key secondary endpoint of phlebotomy rate from the beginning through week 36 was also met, with the mean number of phlebotomies per patient in the divesiran groups significantly reduced, according to a statement.Divesiran was well-tolerated and safety was consistent with previous trials. The company will present full phase 2 data at an upcoming medical congress, according to the company.Shares of Silence Therapeutics rose 26% on Monday.Price: $15.03, Change: $+3.08, Percent Change: +25.77%

$SLN
Wire

Top Midday Gainers

Silence Therapeutics (SLN) reported "positive" topline results from its phase 2 trial of divesiran in 48 phlebotomy-dependent patients with polycythemia vera, according to a statement Monday.Shares soared 29% amid a surge in intraday trading volume to over 13.6 million from a daily average of about 441,000.Blackstone's (BX) portfolio firm Safe Harbor has agreed to acquire MarineMax (HZO) for $53 per share in cash, valuing the recreational boat retailer at about $1.5 billion, including debt, the companies said Monday.Shares of MarineMax surged 45% as intraday trading volume jumped to over 6.28 million from a daily average of roughly 310,000.Teledyne Technologies (TDY) has agreed to acquire X-ray imaging components manufacturer Varex Imaging (VREX) in a $1.1 billion deal that will expand its X-ray device portfolio to include oncology detectors.Shares of Varex surged 48% as intraday trading volume jumped to over 10.9 million from a daily average of roughly 431,000.Price: $696.96, Change: $+5.66, Percent Change: +0.82%

$BX$HZO$SLN$TDY$VREX
Asia Markets

European Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading

European equities traded in the US as American depositary receipts started the week modestly higher late Monday morning, rising 0.14% to 1,959.77 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by furniture maker Natuzzi (NTZ) and petroleum refiner Equinor (EQNR), which advanced 17% and 3.8% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and biotech firm Evaxion (EVAX), which rose 3.6% and 2.3% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and internet advertising firm Criteo (CRTO), which fell 3.4% and 2.3% respectively. They were followed by accommodations booking site trivago (TRVG) and brewing company Anheuser-Busch InBev (BUD), which were down 1.7% and 1.3% respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which surged 43% and 7.7% respectively. They were followed by oil and gas company BP (BP) and biotech firm Trinity Biotech (TRIB), which increased 2.1% and 1.9% respectively.The decliners from the UK and Ireland were led by communications company WPP (WPP) and tobacco company British American Tobacco (BTI), which lost 5.5% and 3.7% respectively. They were followed by telecommunications operator Vodafone Group (VOD), which was off 2.6%.

$AKTX$BP$BTI$BUD$CLLS$CRTO$DBVT$EQNR$EVAX$NTZ$SLN$TRIB$TRVG$VOD$WPP
Asia Markets

European Equities Traded in US as ADRs Advance in Tuesday Trading

European equities traded in the US as American depositary receipts rose late Tuesday morning with the S&P Europe Select ADR Index gaining 0.6% to 1,941.81.From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and medical device maker EDAP TMS (FOCL), which climbed 11% and 5.3%, respectively. They were followed by telecommunications company Nokia (NOK) and internet ad firm Criteo (CRTO), which advanced 5.2% and 3.2%, respectively.The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which fell 2.1% and 1.8%, respectively. They were followed by accommodations platform trivago (TRVG) and pharmaceutical company Ascendis Pharma (ASND), which were down 0.9% each.The gainers from the UK were led by mining company BHP Group (BHP) and pharmaceutical company Silence Therapeutics (SLN), which rose 3.8% and 3%, respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and lender Barclays (BCS), which were up 2.5% and 1.3%, respectively.The decliners from the UK and Ireland were led by medical device maker Smith & Nephew (SNN) and oil and gas company BP (BP), which dropped 5.8% and 4%, respectively. They were followed by educational publisher Pearson (PSO) and oil and gas company Shell (SHEL), which lost 1.6% and 1.4%, respectively.

$ASND$AUTL$BCS$BHP$BP$CRTO$E$EQNR$FOCL$NOK$PSO$SHEL$SLN$SNN$SQNS$TRVG
Asia Markets

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

European equities traded in the US as American depositary receipts started the week off lower late Monday morning, declining 0.35% to 1,925.58 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by accommodations booking site trivago (TRVG) and software firm SAP (SAP), which rose 4% and 3.3%, respectively. They were followed by telecommunications company Ericsson (ERIC) and 3D printer company Materialise (MTLS), which were up 2.5% and 2.4%, respectively.The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and brewing company Anheuser-Busch InBev (BUD), which dropped 2.8% and 2.4%, respectively. They were followed by oil and gas company Eni (E) and biopharmaceutical company argenx (ARGX), which were down 2.2% and 1.9%, respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which advanced 30% and 6.8%, respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company NuCana (NCNA), which increased 5.9% and 3%, respectively.The decliners from the UK and Ireland were led by pharmaceutical company AstraZeneca (AZN) and biotech firm Trinity Biotech (TRIB), which fell 8.1% and 2.9%, respectively. They were followed by oil and gas company BP (BP) and biopharmaceutical company Akari Therapeutics (AKTX), which lost 2.3% and 2.1%, respectively.

$AKTX$ARGX$AUTL$AZN$BDRX$BP$BUD$E$EQNR$ERIC$MTLS$NCNA$SAP$SLN$TRIB$TRVG
Asia Markets

European Equities Traded in US as ADRs Ease in Wednesday Trading

European equities traded in the US as American depositary receipts eased late Wednesday morning with the S&P Europe Select ADR Index down 0.1% to 1,906.06.From continental Europe, the gainers were led by oil and gas company Eni (E) and energy company Equinor (EQNR), which climbed 6.9% and 6.2%, respectively. They were followed by software firm SAP (SAP) and travel-booking company trivago (TRVG), which increased 3% and 2.6%, respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and telecommunications company Nokia (NOK), which fell 4.8% and 3.6%, respectively. They were followed by lenders Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which dropped 2.5% and 2.3%, respectively.The gainers from the UK were led by software firm Endava (DAVA) and oil and gas company BP (BP), which rose 4.2% and 3.7%, respectively. They were followed by oil and gas company Shell (SHEL) and biopharmaceutical company Amarin (AMRN), which climbed 2.5% and 2.4%, respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and pharmaceutical company Silence Therapeutics (SLN), which shed 25% and 4.6%, respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and lender Barclays (BCS), which lost 3.3% and 2.8%, respectively.

$AKTX$AMRN$BBVA$BCS$BDRX$BP$DAVA$E$EQNR$NOK$SAN$SAP$SHEL$SLN$SQNS$TRVG
Asia Markets

European Equities Traded in US as ADRs Ease in Tuesday Trading

European equities traded in the US as American depositary receipts eased late Tuesday morning with the S&P Europe Select ADR Index down 0.1% to 1,903.66.From continental Europe, the gainers were led by consumer goods company Unilever (UL) and software firm SAP (SAP), which climbed 8.6% and 4.8%, respectively. They were followed by pharmaceutical company Sanofi (SNY) and brewing company Anheuser-Busch InBev (BUD), which advanced 3.7% and 3%, respectively.The decliners from continental Europe were led by telecommunications operator Nokia (NOK) and biopharmaceutical company DBV Technologies (DBVT), which dropped 6.3% and 5.1%, respectively. They were followed by medical device maker EDAP TMS (FOCL) and semiconductor company Sequans Communications (SQNS), which lost 3.3% and 3.1%, respectively.The gainers from the UK were led by biotech firm Trinity Biotech (TRIB) and software company Endava (DAVA), which rose 9.6% and 7.9%, respectively. They were followed by pharmaceutical company GSK (GSK) and communications company WPP (WPP), which were up 6.5% and 6.4%, respectively.The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and lender Barclays (BCS), which fell 7.8% and 7.3%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and lender Lloyds Banking Group (LYG), which dropped 7% and 2.5%, respectively.

$BCS$BDRX$BUD$DAVA$DBVT$FOCL$GSK$LYG$NOK$SAP$SLN$SNY$SQNS$TRIB$UL$WPP
Asia Markets

European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading

European equities traded in the US as American depositary receipts started the week slightly higher late Monday morning, rising 0.15% to 1,910.62 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by software firm SAP (SAP) and lender Banco Santander (SAN), which rose 6% and 3.5% respectively. They were followed by biotech firm Evaxion (EVAX) and biopharmaceutical company Grifols (GRFS), which increased 3.3% and 3.2% respectively.The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which fell 3% and 2.6% respectively. They were followed by brewing company Anheuser-Busch InBev (BUD) and biopharmaceutical company argenx (ARGX), which were down 1.8% and 0.7% respectively.The gainers from the UK were led by biopharmaceutical company Akari Therapeutics (AKTX) and telecommunications operator Vodafone Group (VOD), which climbed 9.6% and 5.4% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and pharmaceutical company Silence Therapeutics (SLN), which advanced 5.2% and 4.4% respectively.The decliners from the UK and Ireland were led by oil and gas companies BP (BP) and Shell (SHEL), which dropped 2% and 1% respectively. They were followed by tobacco company British American Tobacco (BTI) and utilities company National Grid (NGG), which lost 0.6% and 0.1% respectively.

$AKTX$ARGX$AUTL$BP$BTI$BUD$E$EQNR$EVAX$GRFS$NGG$SAN$SAP$SHEL$SLN$VOD
Asia Markets

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

European equities traded in the US as American depositary receipts were tracking higher late Friday morning, rising 0.55% to 1,910.34 on the S&P Europe Select ADR Index, which is up about 0.4% for the week so far.From continental Europe, the gainers were led by software firm SAP (SAP) and semiconductor company Sequans Communications (SQNS), which rose 7% and 2.8%, respectively. They were followed by pharmaceutical firm Novo Nordisk (NVO) and lender Banco Santander (SAN), which advanced 2.5% and 2.4%, respectively.The decliners from continental Europe were led by telecommunications company Nokia (NOK) and biopharmaceutical company DBV Technologies (DBVT), which dropped 4.7% and 2.9% respectively. They were followed by internet ad firm Criteo (CRTO) and biotech company BioNTech (BNTX), which lost 2.1% and 1.3% respectively.The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and communications company WPP (WPP), which increased 3.7% and 2.3% respectively. They were followed by medical device maker Smith & Nephew (SNN) and educational publisher Pearson (PSO), which were up 1.7% and 1.6% respectively.The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Bicycle Therapeutics (BCYC), which fell 4.7% and 3% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and biotech firm Autolus Therapeutics (AUTL), which were down 2.5% and 2% respectively.

$AKTX$AUTL$BCYC$BNTX$CRTO$DBVT$NOK$NVO$PSO$SAN$SAP$SLN$SNN$SQNS$WPP

Showing 1-20 of 55

Track with the FINWIRES app suite

FolioX
FolioX
Track SLN in your portfolio
WheelAI
WheelAI
Analyze SLN options with the wheel strategy
StockInsider
StockInsider
See market sentiment on SLN